6 completed, 1 withdrawn. 7 Phase 3, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 7 | Completed 6, Withdrawn 1 |
| Phase 2 | 1 | Withdrawn 1 |
Follow Squamous Cell Lung Cancer: new trials by email Literature Review of Squamous Cell Lung Cancer trials Research Report on Squamous Cell Lung Cancer
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study of Anti-PD-1 AK105 in Patients With Metastatic Squamous Non-small Cell Lung Cancer AK105, Paclitaxel, Carboplatin - Lung Cancer Non-small Cell Stage IV, Squamous Cell Lung Cancer | Phase 3 | Completed | Akeso | 350 | 2018-12-20 | 2024-04-03 |
| Photodynamic Therapy for the Prevention of Lung Cancer Photodynamic Therapy (PDT) - Squamous Cell Lung Cancer, Lung Cancer | Phase 2 / Phase 3 | Withdrawn | University College, London | 2018-09-01 | 2019-02-01 | |
| Trial of Gemcitabine/Carboplatin With or Without Iniparib (SAR240550) (a PARP1 Inhibitor) in Subjects With Previously Untreated Stage IV Squamous Non-Small-Cell Lung Cancer (NSCLC) gemcitabine/carboplatin, gemcitabine/carboplatin plus Iniparib - Squamous Cell Lung Cancer | Phase 3 | Completed | Sanofi | 780 | 2010-03-01 | 2016-03-17 |
| Gefitinib in Treating Patients With Stage IB, II, or IIIA Non-small Cell Lung Cancer That Was Completely Removed by Surgery gefitinib, placebo, laboratory biomarker analysis - Adenocarcinoma of the Lung, Adenosquamous Cell Lung Cancer | Phase 3 | Completed | National Cancer Institute (NCI) | 503 | 2002-09-01 | 2015-01-01 |
| Combination Chemotherapy and Radiation Therapy With or Without Gefitinib in Treating Patients With Stage III Non-Small Cell Lung Cancer That Cannot Be Removed By Surgery cisplatin, docetaxel, etoposide - Adenocarcinoma of the Lung, Bronchoalveolar Cell Lung Cancer | Phase 3 | Completed | National Cancer Institute (NCI) | 840 | 2001-06-01 | 2013-02-27 |
| Combination Chemotherapy Plus Radiation Therapy With or Without AE-941 in Treating Patients With Stage III Non-small Cell Lung Cancer That Cannot Be Removed By Surgery shark cartilage extract AE-941, placebo, cisplatin - Adenocarcinoma of the Lung, Adenosquamous Cell Lung Cancer | Phase 3 | Completed | National Cancer Institute (NCI) | 756 | 2000-03-01 | 2013-01-23 |
| Surgery With or Without Chemotherapy in Treating Patients With Stage I Non-small Cell Lung Cancer paclitaxel, carboplatin, therapeutic conventional surgery - Adenocarcinoma of the Lung, Adenosquamous Cell Lung Cancer | Phase 3 | Completed | National Cancer Institute (NCI) | 500 | 1996-10-01 | 2013-07-03 |
Carcinoma, Non-Small-Cell Lung (5) · Adenocarcinoma of Lung (4) · Adenocarcinoma, Bronchiolo-Alveolar (3) · Lung Neoplasms (1)
Lung Diseases (6) · Neoplasms (6) · Neoplasms by Site (6) · Respiratory Tract Diseases (6) · Respiratory Tract Neoplasms (6) · Thoracic Neoplasms (6) · Bronchial Neoplasms (5) · Carcinoma, Bronchogenic (5) · Lung Neoplasms (5) · Adenocarcinoma (4) · Carcinoma (4) · Neoplasms by Histologic Type (4) · Neoplasms, Glandular and Epithelial (4)
Carboplatin (4) · Paclitaxel (3) · Cisplatin (2) · Gefitinib (2) · Radiation (2) · Radiotherapy (2) · Taxes (2) · Docetaxel (1) · Etoposide (1) · Gemcitabine (1) · Photochemotherapy (1) · Vinorelbine (1) · iniparib (1) · shark cartilage extract (1)
National Cancer Institute (NCI) (4) · Akeso (1) · Sanofi (1) · University College, London (1)
United States (4) · Canada (2) · Belgium (1) · China (1) · France (1) · Germany (1) · Hungary (1) · Israel (1) · Italy (1) · Luxembourg (1) · Netherlands (1) · Poland (1) · Romania (1) · Spain (1) · United Kingdom (1)
Baohui Han, MD (1) · Charles Lu (1) · Gary Strauss (1) · Glennwood Goss (1) · Karen Kelly (1) · Shunchang Jiao, MD (1)
U10CA031946 (1), U10CA032102 (1), U10CA045809 (1)